Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment
Sasanka Chakrabarti, Vineet Kumar Khemka, Anindita Banerjee, et al.
Aging and Disease (2015) Vol. 6, Iss. 4, pp. 282-282
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
Erika N. Cline, Maíra A. Bicca, Kirsten L. Viola, et al.
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. s1, pp. S567-S610
Open Access | Times Cited: 699
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Tiantian Guo, Denghong Zhang, Yuzhe Zeng, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 696
Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice
Vladimir Ilievski, Paulina Zuchowska, Stefan J. Green, et al.
PLoS ONE (2018) Vol. 13, Iss. 10, pp. e0204941-e0204941
Open Access | Times Cited: 285
Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
Gargi Ganguly, Sasanka Chakrabarti, Uttara Chatterjee, et al.
Drug Design Development and Therapy (2017) Vol. Volume11, pp. 797-810
Open Access | Times Cited: 241
Therapies for Prevention and Treatment of Alzheimer’s Disease
Jesus Mendiola-Precoma, Laura C. Berumen, Karla Padilla, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-17
Open Access | Times Cited: 225
The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction
Yuri Zilberter, Misha Zilberter
Journal of Neuroscience Research (2017) Vol. 95, Iss. 11, pp. 2217-2235
Open Access | Times Cited: 192
Neuronal cell death mechanisms in Alzheimer’s disease: An insight
Parul Goel, Sasanka Chakrabarti, Kapil Goel, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 123
Alzheimer’s disease and its treatment–yesterday, today, and tomorrow
A. Y. Kim, Salman Al Jerdi, Ryan B. MacDonald, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 18
Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer’s Disease
Gurjit Kaur Bhatti, Arubala P. Reddy, P. Hemachandra Reddy, et al.
Frontiers in Aging Neuroscience (2020) Vol. 11
Open Access | Times Cited: 116
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Prashanth Gowda, P. Hemachandra Reddy, Subodh Kumar
Ageing Research Reviews (2021) Vol. 73, pp. 101529-101529
Open Access | Times Cited: 102
Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma
Camilla Steen Jensen, Justyna Maria Czarna Bahl, Lærke Borg Østergaard, et al.
Experimental Gerontology (2019) Vol. 121, pp. 91-98
Open Access | Times Cited: 92
An update on the interactions between Alzheimer's disease, autophagy and inflammation
Mehmet Bostancıklıoğlu
Gene (2019) Vol. 705, pp. 157-166
Closed Access | Times Cited: 77
Inflammatory Cascade in Alzheimer’s Disease Pathogenesis: A Review of Experimental Findings
Jade de Oliveira, Ewa Kucharska, Michelle Lima Garcez, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2581-2581
Open Access | Times Cited: 63
Human Gut Microbiota in Health and Alzheimer’s Disease
Leszek Szablewski
Journal of Alzheimer s Disease (2018) Vol. 62, Iss. 2, pp. 549-560
Closed Access | Times Cited: 82
Physiological changes in neurodegeneration — mechanistic insights and clinical utility
Rebekah M. Ahmed, Yazi D. Ke, Steve Vucic, et al.
Nature Reviews Neurology (2018) Vol. 14, Iss. 5, pp. 259-271
Closed Access | Times Cited: 77
Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer’s disease in T2DM patients
Sebastian Bertram, Klara Brixius, Christian Brinkmann
Endocrine (2016) Vol. 53, Iss. 2, pp. 350-363
Closed Access | Times Cited: 75
Metabolic profiling distinguishes three subtypes of Alzheimer's disease
Dale E. Bredesen
Aging (2015) Vol. 7, Iss. 8, pp. 595-600
Open Access | Times Cited: 73
Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia
Małgorzata Bednarska‐Makaruk, Ałła Graban, Anna Wiśniewska, et al.
Biogerontology (2017) Vol. 18, Iss. 4, pp. 561-580
Open Access | Times Cited: 73
Role of Insulin Resistance in the Alzheimer's Disease Progression
Thuy Trang Nguyen, Qui Thanh Hoai Ta, Thi Thuy Dung Nguyen, et al.
Neurochemical Research (2020) Vol. 45, Iss. 7, pp. 1481-1491
Closed Access | Times Cited: 68
Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing
Md. Sahab Uddin, Md. Tanvir Kabir, Philippe Jeandet, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-19
Open Access | Times Cited: 59
Neurodegeneration in type 2 diabetes: Alzheimer's as a case study
J Madhusudhanan, Gowthaman Suresh, Vasudharani Devanathan
Brain and Behavior (2020) Vol. 10, Iss. 5
Open Access | Times Cited: 55
Role of Withaferin A and Its Derivatives in the Management of Alzheimer’s Disease: Recent Trends and Future Perspectives
Rajib Das, Abdur Rauf, Saima Akhter, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3696-3696
Open Access | Times Cited: 43
Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer’s disease models: a systematic review and meta-analysis of preclinical studies
Fanjing Kong, Tianyu Wu, Jiyan Dai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Lecanemab: More Questions Than Answers!
Upinder Kaur, Jaideep Reddy, Ashutosh Tiwari, et al.
Clinical Drug Investigation (2023) Vol. 44, Iss. 1, pp. 1-10
Closed Access | Times Cited: 17
Multiregional analysis of global 5‐methylcytosine and 5‐hydroxymethylcytosine throughout the progression of Alzheimer's disease
Elizabeth M. Ellison, Erin L. Abner, Mark A. Lovell
Journal of Neurochemistry (2016) Vol. 140, Iss. 3, pp. 383-394
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top